Hosseininezhad M, Ghayeghran A R, Nasiri P, Saadat S, Esmaili K, Homaei Rad E et al . Estimation of Median Nerve Axonal Degeneration without Needle Electromyography. Iran J Neurosurg 2021; 7 (1) :23-30
URL:
http://irjns.org/article-1-253-en.html
1- Department of Neurology, Guilan Road Trauma Research Center, Guilan University of Medical Sciences, Rasht, Iran. , hosseininezhadm@gmail.com
2- Department of Neurology, Guilan Road Trauma Research Center, Guilan University of Medical Sciences, Rasht, Iran.
3- Neuroscience Research Center, Guilan University of Medical Sciences, Rasht, Iran.
4- Research Assistant Professor of Health Economics, Guilan Road Trauma Research Center, Guilan University of Medical Sciences, Rasht, Iran.
5- Department of Nursing, Neuroscience Research Center, Guilan University of Medical Sciences, Rasht, Iran.
Abstract: (2615 Views)
Background and Aim: The present study aimed to use the median nerve Compound Muscle Action Potential (CMAP) amplitude by stimulation at the palm instead of Abductor Pollicis Brevis (APB) needle Electromyography (EMG) for determining axonal loss in patients with Carpal Tunnel Syndrome (CTS).
Methods and Materials/Patients: This study was performed on 180 patients with CTS referred to the Electrodiagnostic (EDX) Center, Poursina Hospital, Guilan Province, Iran, in 2018-19. In this study, the APB needle EMG diagnostic test was used as the gold standard, and median nerve CMAP amplitude with stimulation at the palm and wrist were used to compare the two nerve stimulation tests.
Results: All of the cases with abnormal amplitude loss detected by median nerve stimulation at the palm also had an axonal loss in the needle EMG of APB. So this test could be a good indicator of axonal loss if there is an abnormality (sensitivity: 73%, specificity: 100%). The results with wrist stimulation were not as accurate as of the palm stimulation, and some cases with decreased CMAP amplitude of median nerve had normal needle EMG of APB muscle (sensitivity: 86.6%, specificity: 94.9%).
Conclusion: In cases with CTS, the abnormally decreased amplitude of the median nerve detected by stimulation at the palm could be a good indicator of axonal loss.
Full Text [PDF 616 kb]
(738 Downloads)
| |
Full Text (HTML) (1345 Views)
• All patients with carpal tunnel syndrome with axonal degeneration in needle EMG of abductor pollicis brevis (APB) muscle showed abnormal amplitude loss during median nerve stimulation at the palm.
• The sensitivity and specificity of recording median nerve amplitude with stimulation at palm were 73% and 100%, respectively.
• The sensitivity and specificity of recording median nerve amplitude with stimulation at the wrist were 86.6% and 94.9%, respectively.
Plain Language Summary
In this project, we intend to investigate whether median nerve stimulation at the palm and wrist could accurately detect axonal loss in patients with Carpal Tunnel Syndrome (CTS) similar to Electromyography (EMG) on the Abductor Pollicis Brevis (APB) muscle. In this regard, we studied 180 patients with CTS referred to the Electrodiagnostic (EDX) Center at Poursina Hospital, Guilan Province, Iran, between 2018 and 2019. We determined the signs of axonal loss in the patients using two tests, including median nerve stimulation at palm and wrist. We compared the results of these tests with EMG outputs for APB as a gold standard to clarify the sensitivity and specificity of two tests to diagnose axonal loss in CTS patients. Our findings showed that an abnormal amplitude loss during median nerve stimulation at palm like the axonal loss diagnosed by EMG of APB was observed in all patients. We estimated the sensitivity of 73% and 86% and the specificity of 100% and 94.9% for median nerve stimulation at palm and wrist, respectively. As a result, we found an abnormal amplitude loss during median nerve stimulation at palm that could be a good indicator for diagnosing axonal loss in CTS patients. This test might be used instead of the EMG of APB.
Type of Study:
Research |
Subject:
Basic Neurosurgery